Summit Securities Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,000
Closed -$50K 1260
2025
Q4
$50K Buy
+10,000
New +$52.1K 0.01% 614
2025
Q1
Sell
-77,000
Closed -$304K 993
2024
Q4
$304K Buy
77,000
+27,000
+54% +$121K 0.06% 162
2024
Q3
$293K Hold
50,000
0.08% 137
2024
Q2
$216K Buy
+50,000
New +$240K 0.04% 158
2023
Q2
Sell
-200,000
Closed -$1.64M 1019
2023
Q1
$1.64M Buy
200,000
+199,500
+39,900% +$2.2M 0.14% 72
2022
Q4
$6K Buy
+500
New +$5.81K ﹤0.01% 1072
2022
Q3
Sell
-217,500
Closed -$3.32M 1079
2022
Q2
$3.32M Buy
+217,500
New +$3.91M 0.41% 42
2022
Q1
Sell
-300
Closed -$7K 1251
2021
Q4
$7K Buy
+300
New +$6.43K ﹤0.01% 772

Other funds holding MPT

Summit Securities Group's MPT Position: Q1 2026 in Review

Summit Securities Group reduced its Medical Properties Trust (MPT) stake by 96% in Q1 2026, selling an estimated $404K and leaving 3,200 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Summit Securities Group first reported a position in MPT in Q4 2013 and has held it in 16 quarters since. The position peaked at $606K in Q3 2015. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Summit Securities Group held 3,200 shares of Medical Properties Trust worth $14.8K as of Q1 2026.
  • Summit Securities Group sold 77,400 Medical Properties Trust shares in Q1 2026, an estimated $404K.
  • Medical Properties Trust made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #587 holding.
  • Summit Securities Group first reported a position in Medical Properties Trust in Q4 2013 and has held it in 16 quarters since.
  • Summit Securities Group's Medical Properties Trust position peaked at $606K in Q3 2015.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.